Decoding the role of the CCL2/CCR2 axis in Alzheimer’s disease and innovating therapeutic approaches: Keeping All options open-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Decoding the role of the CCL2/CCR2 axis in Alzheimer’s disease and innovating therapeutic approaches: Keeping All options open

Published:2024-06 Issue: Volume:135 Page:112328
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Arfaei Reyhaneh,Mikaeili Narges,Daj Fatemeh,Boroumand Armin,Kheyri Abbas,Yaraghi Pegah,Shirzad Zahra,Keshavarz Mohammad,Hassanshahi Gholamhossein,Jafarzadeh Abdollah,Shahrokhi Vahid Mohammadi,Khorramdelazad Hossein^ORCID

Publisher

Elsevier BV

Reference151 articles.

1. Chronic pain accelerates cognitive impairment by reducing hippocampal neurogenesis may via CCL2/CCR2 signaling in APP/PS1 mice;Chen;Brain Res. Bull.,2023

2. CCL2 and neuronal inflammation: implications for neurodegenerative diseases;Zeng;bioRxiv,2023

3. Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future;Zhang;Signal Transduct. Target. Ther.,2023

4. Receptor–ligand interaction controls microglial chemotaxis and amelioration of Alzheimer's disease pathology;Lau;J. Neurochem.,2023

5. Microglia biology: one century of evolving concepts;Prinz;Cell,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP